# Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India

> **NCT00074841** · PHASE2,PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 230 (actual)

## Conditions studied

- PLASMODIUM FALCIPARUM MALARIA

## Interventions

- **DRUG:** Azithromycin/Chloroquine
- **DRUG:** Sulfadoxine-Pyrimethamine/Chloroquine

## Key facts

- **NCT ID:** NCT00074841
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2011-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00074841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00074841, "Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00074841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*